IMMIX BIOPHARMA INC.
1.6000
05-November-24 14:59:59
15 minutes delayed
Stocks
+0.0200
+1.27%
Today's range
1.4800 - 1.6000
ISIN
N/A
Source
NASDAQ
-
10 Jul 2023 08:47:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Subsidiary Nexcella Completes Pre-IND Meeting with FDA on NXC-201 US Clinical Trial
26 Jun 2023 08:49:00 By Nasdaq GlobeNewswire
-
22 Jun 2023 08:53:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 08:45:00 By Nasdaq GlobeNewswire
-
16 Jun 2023 08:43:00 By Nasdaq GlobeNewswire
-
Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program
14 Jun 2023 06:30:00 By Nasdaq GlobeNewswire
-
12 Jun 2023 08:49:00 By Nasdaq GlobeNewswire
-
26 May 2023 08:53:00 By Nasdaq GlobeNewswire
-
04 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
23 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
Immix Biopharma Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
10 Mar 2023 18:45:20 By Nasdaq GlobeNewswire
-
06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
27 Feb 2023 07:45:00 By Nasdaq GlobeNewswire
-
15 Feb 2023 07:30:00 By Nasdaq GlobeNewswire